These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1903576)

  • 21. Contrast-enhanced MR angiography for the diagnosis of intracranial vascular disease: optimal dose of gadopentetate dimeglumine.
    Jung HW; Chang KH; Choi DS; Han MH; Han MC
    AJR Am J Roentgenol; 1995 Nov; 165(5):1251-5. PubMed ID: 7572513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detecting pulmonary abnormalities on magnetic resonance images in patients with usual interstitial pneumonitis: effect of varying window settings and gadopentetate dimeglumine.
    King MA; Bergin CJ; Ghadishah E; Yi ES; Clark JB
    Acad Radiol; 1996 Apr; 3(4):300-7. PubMed ID: 8796678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MR diagnosis of paraganglioma of the head and neck: value of contrast enhancement.
    van Gils AP; van den Berg R; Falke TH; Bloem JL; Prins HJ; Dillon EH; van der Mey AG; Pauwels EK
    AJR Am J Roentgenol; 1994 Jan; 162(1):147-53. PubMed ID: 8273654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spleen: dynamic enhancement patterns on gradient-echo MR images enhanced with gadopentetate dimeglumine.
    Semelka RC; Shoenut JP; Lawrence PH; Greenberg HM; Madden TP; Kroeker MA
    Radiology; 1992 Nov; 185(2):479-82. PubMed ID: 1410358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MR imaging of soft-tissue masses: role of gadopentetate dimeglumine.
    Benedikt RA; Jelinek JS; Kransdorf MJ; Moser RP; Berrey BH
    J Magn Reson Imaging; 1994; 4(3):485-90. PubMed ID: 8061453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sarcoidosis of the CNS: comparison of unenhanced and enhanced MR images.
    Sherman JL; Stern BJ
    AJR Am J Roentgenol; 1990 Dec; 155(6):1293-301. PubMed ID: 2122683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MR imaging of Hippel-Lindau disease: value of gadopentetate dimeglumine.
    Nelson DR; Yuh WT; Waziri MH; Ryals TJ; Sato Y; Kao SC; Hawes DR; Williams RD
    J Magn Reson Imaging; 1991; 1(4):469-76. PubMed ID: 1790370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracranial lesion enhancement with gadolinium: T1-weighted spin-echo versus three-dimensional Fourier transform gradient-echo MR imaging.
    Mirowitz SA
    Radiology; 1992 Nov; 185(2):529-34. PubMed ID: 1410367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benign lumbar arachnoiditis: MR imaging with gadopentetate dimeglumine.
    Johnson CE; Sze G
    AJNR Am J Neuroradiol; 1990; 11(4):763-70. PubMed ID: 2114765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic pancreatitis: MR imaging features before and after administration of gadopentetate dimeglumine.
    Semelka RC; Shoenut JP; Kroeker MA; Micflikier AB
    J Magn Reson Imaging; 1993; 3(1):79-82. PubMed ID: 8428105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebral infarction: assessment of patterns using ultra-fast MR contrast imaging.
    Lee C; Dean BL; Kirsch JE; Runge VM; Dempsey RJ; Howard RS; Pettigrew LC
    AJNR Am J Neuroradiol; 1992; 13(1):277-9. PubMed ID: 1595458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnetic resonance imaging of normal meningeal enhancement at 1.5 T.
    Quint DJ; Eldevik OP; Cohen JK
    Acad Radiol; 1996 Jun; 3(6):463-8. PubMed ID: 8796702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of gadolinium on the sensitivity and specificity of MR in the initial diagnosis of multiple sclerosis.
    Tas MW; Barkhol F; van Walderveen MA; Polman CH; Hommes OR; Valk J
    AJNR Am J Neuroradiol; 1995 Feb; 16(2):259-64. PubMed ID: 7726070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rectal carcinoma: prospective comparison of conventional and gadopentetate dimeglumine enhanced fat-suppressed MR imaging.
    Okizuka H; Sugimura K; Yoshizako T; Kaji Y; Wada A
    J Magn Reson Imaging; 1996; 6(3):465-71. PubMed ID: 8724412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is Gd-DTPA required for routine cranial MR imaging?
    Elster AD; Moody DM; Ball MR; Laster DW
    Radiology; 1989 Oct; 173(1):231-8. PubMed ID: 2781014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MR diagnosis of head and neck tumors: comparison of contrast enhancement with triple-dose gadodiamide and standard-dose gadopentetate dimeglumine in the same patients.
    Vogl TJ; Mack MG; Juergens M; Stark M; Pegios W; Bergman C; Grevers G; Western A
    AJR Am J Roentgenol; 1994 Aug; 163(2):425-32. PubMed ID: 8037044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MR imaging of tuberous sclerosis: pathogenesis of this phakomatosis, use of gadopentetate dimeglumine, and literature review.
    Braffman BH; Bilaniuk LT; Naidich TP; Altman NR; Post MJ; Quencer RM; Zimmerman RA; Brody BA
    Radiology; 1992 Apr; 183(1):227-38. PubMed ID: 1549677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic value of gadopentetate dimeglumine for 1.5-T MR imaging of musculoskeletal masses: comparison with unenhanced T1- and T2-weighted imaging.
    Rosenthal RE; Wozney P
    J Magn Reson Imaging; 1991; 1(5):547-51. PubMed ID: 1790379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MR arthrography of the shoulder with gadopentetate dimeglumine: influence of concentration, iodinated contrast material, and time on signal intensity.
    Kopka L; Funke M; Fischer U; Keating D; Oestmann J; Grabbe E
    AJR Am J Roentgenol; 1994 Sep; 163(3):621-3. PubMed ID: 8079856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MR imaging of optic nerve lesions: value of gadopentetate dimeglumine and fat-suppression technique.
    Hendrix LE; Kneeland JB; Haughton VM; Daniels DL; Szumowski J; Williams AL; Mark LP; Czervionke LF
    AJNR Am J Neuroradiol; 1990; 11(4):749-54. PubMed ID: 2114763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.